Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05259865Suspended

Pharmacogenetic Testing and Chronic Pain

Role: lead

NCT05474066Recruiting

ERP Changes Pre and Post Military Changes

Role: lead

NCT05259878Suspended

Adverse Childhood Events Chronic Pain

Role: lead

NCT05469243Unknown

Psychedelic Therapy for Wellness Studies Retrospectively

Role: lead

NCT05367531Not ApplicableUnknown

Assessment of Injectable Medication Platforms

Role: lead

NCT05283070Unknown

Correlating Heart Rate Variability and Chronic Pain

Role: lead

NCT05270070Completed

Digital Versus Traditional Booking System for Clinical Appointments

Role: lead

NCT03625271Not ApplicableUnknown

The Canadian Armed Forces PEER Study

Role: collaborator

NCT03464877Not ApplicableCompleted

Prognostic Factors of a Favorable Outcome Following an Exercise Program for Soldiers With Low Back Pain

Role: collaborator

NCT02577510Phase 3Completed

Comparing Ways to Freeze the Nerve That Provides Thigh Sensation

Role: lead

All 10 trials loaded